HER2-positive Breast Cancer Clinical Trials in Shanghai
2 recruitingShanghai, China
Showing 1–2 of 2 trials
Recruiting
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
Breast CancerHER2-low Breast CancerHER2-positive Breast Cancer+1 more
Daiichi Sankyo800 enrolled54 locationsNCT06210776
Recruiting
Not Applicable
Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer
HER2-positive Breast Cancer
Huashan Hospital10 enrolled1 locationNCT05982626